title: Adenovirus serotype 5 neutralizing antibodies target both hexon and fiber following vaccination and natural infection.
abstract: The immunogenicity of adenovirus serotype 5 (Ad5) vectors has been shown to be suppressed by neutralizing antibodies (NAbs) directed primarily against the hexon hypervariable regions (HVRs). However, the role of NAbs directed against other capsid components, particularly the adenovirus fiber, remains unclear. Here we show that Ad5 NAbs target both hexon and fiber following vaccination and natural infection. Utilizing neutralization assays with capsid chimeric vectors, we observed that NAb responses to hexon appeared dominant and NAb responses against fiber were subdominant in sera from vaccinated mice, vaccinated humans, and naturally exposed humans. A novel chimeric Ad5 vector in which both the hexon HVRs and the fiber knob were exchanged nearly completely evaded Ad5-specific NAbs both in vitro and in vivo.
authors.affiliation: Division of Vaccine Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
authors.forename: Ritu R
authors.initials: RR
authors.lastname: Bradley
authors.forename: Diana M
authors.initials: DM
authors.lastname: Lynch
authors.forename: Mark J
authors.initials: MJ
authors.lastname: Iampietro
authors.forename: Erica N
authors.initials: EN
authors.lastname: Borducchi
authors.forename: Dan H
authors.initials: DH
authors.lastname: Barouch
mesh_terms: D000258:Adenovirus Infections, Human / Q000276:immunology* / Q000821:virology; D000260:Adenoviruses, Human / Q000235:genetics / Q000276:immunology* / Q000502:physiology; D000818:Animals; D057134:Antibodies, Neutralizing / Q000276:immunology*; D000914:Antibodies, Viral / Q000276:immunology*; D036022:Capsid Proteins / Q000235:genetics / Q000276:immunology*; D005822:Genetic Vectors / Q000235:genetics / Q000276:immunology / Q000502:physiology; D006801:Humans; D051379:Mice; D008810:Mice, Inbred C57BL; D011993:Recombinant Fusion Proteins / Q000235:genetics / Q000276:immunology; D014611:Vaccination
chemical_list: D057134:Antibodies, Neutralizing; D000914:Antibodies, Viral; D036022:Capsid Proteins; D011993:Recombinant Fusion Proteins; C018315:hexon capsid protein, Adenovirus
references.citation: J Virol. 2003 Oct;77(19):10366-75
references.pmid: 12970421
references.citation: Nature. 2006 May 11;441(7090):239-43
references.pmid: 16625206
references.citation: J Virol. 2010 Jan;84(1):630-8
references.pmid: 19846512
references.citation: J Gen Virol. 2002 Jan;83(Pt 1):151-155
references.pmid: 11752711
references.citation: Nat Med. 2009 Aug;15(8):873-5
references.pmid: 19620961
references.citation: J Immunol. 2005 Jun 1;174(11):7179-85
references.pmid: 15905562
references.citation: Nature. 2002 Jan 17;415(6869):331-5
references.pmid: 11797011
references.citation: J Immunol. 2004 May 15;172(10):6290-7
references.pmid: 15128818
references.citation: J Virol. 1998 Mar;72(3):2388-97
references.pmid: 9499099
references.citation: Clin Infect Dis. 2008 Jun 1;46(11):1769-81
references.pmid: 18433307
references.citation: J Virol. 2003 Aug;77(15):8263-71
references.pmid: 12857895
references.citation: Emerg Infect Dis. 2006 Oct;12(10):1596-9
references.pmid: 17176582
references.citation: Vaccine. 2011 Jul 18;29(32):5203-9
references.pmid: 21619905
references.citation: Hum Gene Ther. 2002 Jan 20;13(2):311-20
references.pmid: 11812286
references.citation: J Virol. 2006 Dec;80(24):11991-7
references.pmid: 17005652